Product Information

DILTIAZEM 24H ER(LA) 360 MG TB is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $1.7546 per EA under NDC 70436019904. Its NADAC has been published 185 times since May 3, 2023.

FDA first approved this application on Mar 7, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DILTIAZEM 24H ER(LA) 360 MG TB

Diltiazem Hydrochloride
$1.7546per EA

Strength

360 mg/1

NDC

70436019904

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

DILTIAZEM HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA216439

FDA Approved

3/7/2023

TE Code

AB

On Market Since

3/20/2023

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A4 Inhibitors

Price Statistics

The NADAC for DILTIAZEM 24H ER(LA) 360 MG TB has been published 185 times since May 3, 2023, and over the history we have for it it has declined 39.4%. The table below summarizes its recorded NADAC range and movement.

Current price$1.7546 per EA
All-time high$2.9914 (Oct 11, 2023)
All-time low$1.7546 (Oct 21, 2026)
52-week high$2.4017
52-week low$1.7546
Median price$2.5906
Average price$2.5137
Largest weekly change+33.4% (Jun 19, 2024)
Weeks tracked185
Tracking sinceMay 3, 2023

Price History

1W

0.0%

1M

-4.3%

3M

-15.4%

6M

-22.4%

1Y

-32.6%

3Y

-40.3%

5Y

N/A

All

-39.4%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DILTIAZEM 24H ER(LA) 360 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 24H ER(LA) 360 MG TB, manufactured by Slate Run Pharmaceuticals LLC, is $1.7546 per EA (NDC 70436019904), effective Nov 11, 2026.

How has the price of DILTIAZEM 24H ER(LA) 360 MG TB changed over time?

Over the history we have for it, the NADAC for DILTIAZEM 24H ER(LA) 360 MG TB has declined 39.4%. It has been tracked across 185 weekly CMS publications since May 3, 2023.

What are the highest and lowest recorded NADAC prices for DILTIAZEM 24H ER(LA) 360 MG TB?

Since May 3, 2023, the NADAC for DILTIAZEM 24H ER(LA) 360 MG TB has ranged from a low of $1.7546 (Oct 21, 2026) to a high of $2.9914 (Oct 11, 2023), with a median of $2.5906 per EA.

Are there cheaper alternatives to DILTIAZEM 24H ER(LA) 360 MG TB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DILTIAZEM 24H ER(LA) 360 MG TB in a comparable dosage form, but none are currently priced below it.

Who manufactures DILTIAZEM 24H ER(LA) 360 MG TB?

DILTIAZEM 24H ER(LA) 360 MG TB (NDC 70436019904) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.